Inflammation triggers production of dimethylsphingosine from oligodendrocytes

Neuroscience

Volumn 279, Issue , 2014, Pages 113-121

  Chen, Y J ^a   Hill, S ^b   Huang, H ^b   Taraboletti, A ^b   Cho, K ^a   Gallo, R ^a   Manchester, M ^c   Shriver, L P ^a,b   Patti, G J ^a  

^a WASHINGTON UNIVERSITY   (United States)

^b UNIVERSITY OF AKRON   (United States)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Astrocytes; Dimethylsphingosine; Metabolomics; Multiple sclerosis; Neuropathic pain; Oligodendrocytes

Indexed keywords

N,N DIMETHYLSPHINGOSINE; N,N-DIMETHYLSPHINGOSINE; PHOSPHOTRANSFERASE; SPHINGOSINE; SPHINGOSINE KINASE;

ANIMAL CELL; ARTICLE; ASTROCYTE; CELL DAMAGE; CHRONIC PAIN; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DEMYELINATING NEUROPATHY; HUMAN; HUMAN CELL; MULTIPLE SCLEROSIS; NERVOUS SYSTEM INFLAMMATION; NEUROPATHIC PAIN; NONHUMAN; OLIGODENDROGLIA; PROTEIN SECRETION; PROTEIN SYNTHESIS; RAT; SIGNAL TRANSDUCTION; WHITE MATTER; ANALOGS AND DERIVATIVES; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL LINE; IMMUNOLOGY; METABOLISM;

ANIMALS; ASTROCYTES; CELL LINE; HUMANS; MULTIPLE SCLEROSIS; OLIGODENDROGLIA; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); RATS; SPHINGOSINE;

EID: 84907536966     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2014.08.011     Document Type: Article

References (41)

1. Aicher S.A., Silverman M.B., Winkler C.W., Bebo B.F. Hyperalgesia in an animal model of multiple sclerosis. Pain 2004, 110:560-570.
2. Baerwald K.D., Popko B. Developing and mature oligodendrocytes respond differently to the immune cytokine interferon-gamma. J Neurosci Res 1998, 52:230-239.
3. Benardais K., Kotsiari A., Skuljec J., Koutsoudaki P.N., Gudi V., Singh V., Vulinovic F., Skripuletz T., Stangel M. Cuprizone [bis(cyclohexylidenehydrazide)] is selectively toxic for mature oligodendrocytes. Neurotox Res 2013, 24:244-250.
4. Bligh E.G., Dyer W.J. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 1959, 37:911-917.
5. Breij E.C., Brink B.P., Veerhuis R., van den Berg C., Vloet R., Yan R., Dijkstra C.D., van der Valk P., Bo L. Homogeneity of active demyelinating lesions in established multiple sclerosis. Ann. Neurol. 2008, 63:16-25.
6. Buntinx M., Gielen E., Van Hummelen P., Raus J., Ameloot M., Steels P., Stinissen P. Cytokine-induced cell death in human oligodendroglial cell lines. II: Alterations in gene expression induced by interferon-gamma and tumor necrosis factor-alpha. J Neurosci Res 2004, 76:846-861.
7. Camprubi-Robles M., Mair N., Andratsch M., Benetti C., Beroukas D., Rukwied R., Langeslag M., Proia R.L., Schmelz M., Ferrer Montiel A.V., Haberberger R.V., Kress M. Sphingosine-1-phosphate-induced nociceptor excitation and ongoing pain behavior in mice and humans is largely mediated by S1P3 receptor. J Neurosci 2013, 33:2582-2592.
8. Chambers M.C., Maclean B., Burke R., Amodei D., Ruderman D.L., Neumann S., Gatto L., Fischer B., Pratt B., Egertson J., Hoff K., Kessner D., Tasman N., Shulman N., Frewen B., Baker T.A., Brusniak M.Y., Paulse C., Creasy D., Flashner L., Kani K., Moulding C., Seymour S.L., Nuwaysir L.M., Lefebvre B., Kuhlmann F., Roark J., Rainer P., Detlev S., Hemenway T., Huhmer A., Langridge J., Connolly B., Chadick T., Holly K., Eckels J., Deutsch E.W., Moritz R.L., Katz J.E., Agus D.B., MacCoss M., Tabb D.L., Mallick P. A cross-platform toolkit for mass spectrometry and proteomics. Nat Biotechnol 2012, 30:918-920.
9. Clark A.K., Old E.A., Malcangio M. Neuropathic pain and cytokines: current perspectives. J Pain Res 2013, 6:803-814.
10. Corbin J.G., Kelly D., Rath E.M., Baerwald K.D., Suzuki K., Popko B. Targeted CNS expression of interferon-gamma in transgenic mice leads to hypomyelination, reactive gliosis, and abnormal cerebellar development. Mol Cell Neurosci 1996, 7:354-370.
11. Ducreux D., Attal N., Parker F., Bouhassira D. Mechanisms of central neuropathic pain: a combined psychophysical and fMRI study in syringomyelia. Brain 2006, 129:963-976.
12. Edsall L.C., Van Brocklyn J.R., Cuvillier O., Kleuser B., Spiegel S. N,N-dimethylsphingosine is a potent competitive inhibitor of sphingosine kinase but not of protein kinase C: modulation of cellular levels of sphingosine 1-phosphate and ceramide. Biochemistry 1998, 37:12892-12898.
13. Fei F., Bowdish D.M., McCarry B.E. Comprehensive and simultaneous coverage of lipid and polar metabolites for endogenous cellular metabolomics using HILIC-TOF-MS. Anal Bioanal Chem 2014, 406:3723-3733.
14. Foley P.L., Vesterinen H.M., Laird B.J., Sena E.S., Colvin L.A., Chandran S., Macleod M.R., Fallon M.T. Prevalence and natural history of pain in adults with multiple sclerosis: systematic review and meta-analysis. Pain 2012, 632-642.
15. Gao Y.J., Zhang L., Samad O.A., Suter M.R., Yasuhiko K., Xu Z.Z., Park J.Y., Lind A.L., Ma Q., Ji R.R. JNK-induced MCP-1 production in spinal cord astrocytes contributes to central sensitization and neuropathic pain. J Neurosci 2009, 29:4096-4108.
16. Jay G.W., Barkin R.L. Neuropathic pain: etiology, pathophysiology, mechanisms, and evaluations. Disease-a-Month 2014, 60:6-47.
17. Lee Y.K., Kim H.L., Kim Y.L., Im D.S. Multiple actions of dimethylsphingosine in 1321N1 astrocytes. Mol Cells 2007, 23:11-16.
18. Lin Y., Jamison S., Lin W. Interferon-gamma activates nuclear factor-kappa B in oligodendrocytes through a process mediated by the unfolded protein response. PLoS One 2012, 7:e36408.
19. Liu T., Jiang C.Y., Fujita T., Luo S.W., Kumamoto E. Enhancement by interleukin-1beta of AMPA and NMDA receptor-mediated currents in adult rat spinal superficial dorsal horn neurons. Mol Pain 2013, 9:16.
20. Lu J., Kurejova M., Wirotanseng L.N., Linker R.A., Kuner R., Tappe-Theodor A. Pain in experimental autoimmune encephalitis: a comparative study between different mouse models. J Neuroinflamm 2012, 9:233.
21. Medlock K.A., Merrill A.H. Rapid turnover of sphingosine synthesized de novo from [14C]serine by Chinese hamster ovary cells. Biochem Biophys Res Commun 1988, 157:232-237.
22. Nikolskiy I., Mahieu N.G., Chen Y.J., Tautenhahn R., Patti G.J. An untargeted metabolomic workflow to improve structural characterization of metabolites. Anal Chem 2013, 85:7713-7719.
23. Nordstrom A., Lewensohn R. Metabolomics: moving to the clinic. J Neuroimmune Pharmacol 2009, 5:4-17.
24. Olechowski C.J., Parmar A., Miller B., Stephan J., Tenorio G., Tran K., Leighton J., Kerr B.J. A diminished response to formalin stimulation reveals a role for the glutamate transporters in the altered pain sensitivity of mice with experimental autoimmune encephalomyelitis (EAE). Pain 2010, 149:565-572.
25. Patti G.J., Yanes O., Shriver L.P., Courade J.P., Tautenhahn R., Manchester M., Siuzdak G. Metabolomics implicates altered sphingolipids in chronic pain of neuropathic origin. Nat Chem Biol 2012, 8:232-234.
26. Petrossian T.C., Clarke S.G. Uncovering the human methyltransferasome. Mol Cell Proteomics 2011, 10(M110):000976.
27. Sherwin C., Fern R. Acute lipopolysaccharide-mediated injury in neonatal white matter glia: role of TNF-alpha, IL-1beta, and calcium. J Immunol 2005, 175:155-161.
28. Smith C.A., Want E.J., O'Maille G., Abagyan R., Siuzdak G. XCMS: processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification. Anal Chem 2006, 78:779-787.
29. Solaro C., Trabucco E., Messmer Uccelli M. Pain and multiple sclerosis: pathophysiology and treatment. Curr Neurol Neurosci Rep 2013, 13:320.
30. Stenager E., Knudsen L., Jensen K. Acute and chronic pain syndromes in multiple sclerosis. A 5-year follow-up study. Ital J Neurol Sci 1995, 16:629-632.
31. Tautenhahn R., Cho K., Uritboonthai W., Zhu Z.J., Patti G.J., Siuzdak G. An accelerated workflow for untargeted metabolomics using the METLIN database. Nat Biotechnol 2012, 30:826-828.
32. Tautenhahn R., Patti G.J., Rinehart D., Siuzdak G. XCMS online: a web-based platform to process untargeted metabolomic data. Anal Chem 2012, 84:5035-5039.
33. Trescot A.M., Datta S., Lee M., Hansen H. Opioid pharmacology. Pain Physician 2008, 11:S133-S153.
34. Vidaurre O.G., Haines J.D., Katz Sand I., Adula K.P., Huynh J.L., McGraw C.A., Zhang F., Varghese M., Sotirchos E., Bhargava P., Bandaru V.V., Pasinetti G., Zhang W., Inglese M., Calabresi P.A., Wu G., Miller A.E., Haughey N.J., Lublin F.D., Casaccia P. Cerebrospinal fluid ceramides from patients with multiple sclerosis impair neuronal bioenergetics. Brain 2014, 137:2271-2286.
35. Vranken J.H. Elucidation of pathophysiology and treatment of neuropathic pain. Cent Nerv Syst Agents Med Chem 2012, 12:304-314.
36. Wikoff W.R., Pendyala G., Siuzdak G., Fox H.S. Metabolomic analysis of the cerebrospinal fluid reveals changes in phospholipase expression in the CNS of SIV-infected macaques. J Clin Investig 2008, 118:2661-2669.
37. Xu Y.F., Amador-Noguez D., Reaves M.L., Feng X.J., Rabinowitz J.D. Ultrasensitive regulation of anapleurosis via allosteric activation of PEP carboxylase. Nat Chem Biol 2012, 8:562-568.
38. Yao S.Y., Natarajan C., Sriram S. NNOS mediated mitochondrial injury in LPS stimulated oligodendrocytes. Mitochondrion 2012, 12:336-344.
39. Zendedel A., Beyer C., Kipp M. Cuprizone-induced demyelination as a tool to study remyelination and axonal protection. J Mol Neurosci 2013, 51:567-572.
40. Zhang Y., Berka V., Song A., Sun K., Wang W., Zhang W., Ning C., Li C., Zhang Q., Bogdanov M., Alexander D.C., Milburn M.V., Ahmed M.H., Lin H., Idowu M., Zhang J., Kato G.J., Abdulmalik O.Y., Zhang W., Dowhan W., Kellems R.E., Zhang P., Jin J., Safo M., Tsai A.L., Juneja H.S., Xia Y. Elevated sphingosine-1-phosphate promotes sickling and sickle cell disease progression. J Clin Investig 2014, 124:2750-2761.
41. Zhu Z.J., Schultz A.W., Wang J., Johnson C.H., Yannone S.M., Patti G.J., Siuzdak G. Liquid chromatography quadrupole time-of-flight mass spectrometry characterization of metabolites guided by the METLIN database. Nat Protoc 2013, 8:451-460.